US20200337710A1 - Aneurysm device and delivery system - Google Patents
Aneurysm device and delivery system Download PDFInfo
- Publication number
- US20200337710A1 US20200337710A1 US16/924,571 US202016924571A US2020337710A1 US 20200337710 A1 US20200337710 A1 US 20200337710A1 US 202016924571 A US202016924571 A US 202016924571A US 2020337710 A1 US2020337710 A1 US 2020337710A1
- Authority
- US
- United States
- Prior art keywords
- braid
- segment
- distal
- aneurysm
- proximal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010002329 Aneurysm Diseases 0.000 title claims abstract description 124
- 239000000463 material Substances 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 20
- 210000005166 vasculature Anatomy 0.000 description 11
- 238000013459 approach Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000003073 embolic effect Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 229910001000 nickel titanium Inorganic materials 0.000 description 6
- 238000004891 communication Methods 0.000 description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000000788 chromium alloy Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000009963 fulling Methods 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000006833 reintegration Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/361—Image-producing devices, e.g. surgical cameras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/005—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12081—Details concerning the detachment of the occluding device from the introduction device detachable by inflation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
- A61F2002/9665—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
Definitions
- This disclosure relates to medical instruments, and more particularly, delivery systems for aneurysm therapy.
- Aneurysms can be complicated and difficult to treat. For example, treatment access may be limited or unavailable when an aneurysm is located proximate critical tissues. Such factors are of particular concern with cranial aneurysms due to the brain tissue surrounding cranial vessels the corresponding limited treatment access.
- occlusive devices have typically incorporated multiple embolic coils that are delivered to the vasculature using microcatheter delivery systems.
- embolic coils that are delivered to the vasculature using microcatheter delivery systems.
- a delivery catheter with embolic coils is typically first inserted into non-cranial vasculature through a femoral artery in the hip or groin area. Thereafter, the catheter is guided to a location of interest within the cranium. The sac of the aneurysm can then be filled with the embolic material to create a thrombotic mass that protects the arterial walls from blood flow and related pressure.
- occlusive devices do have certain shortcomings, including mass effect, which can cause compression on the brain and its nerves.
- occlusive approach endeavors to deliver and treat the entrance or “neck” of the aneurysm as opposed to the volume of the aneurysm.
- neck approaches, by minimizing blood flow across the neck, then a cessation of flow into the aneurysm may be achieved.
- a thrombotic mass may naturally form without having to deliver embolic materials, as previously described.
- embolic material since a natural mass can improve healing by reducing possible distention from arterial walls and permits reintegration into the original parent vessel shape along the neck plane of the aneurysm. It is understood that the neck plane is an imaginary surface where the inner most layer of the parent wall would be but for the aneurysm.
- neck-occlusive approaches are not without drawbacks. It is desired to block the neck of the aneurysm in the parent vessel. Further, embolic coils do not always effectively treat aneurysms as re-canalization of the aneurysm and/or coil compaction can occur over time.
- the present disclosure relates to a self-expanding braid for treating an aneurysm.
- the braid can include a lumen with a distal end opposite a proximal end. Translating the braid can cause the delivery portion to expand and form an occlusive sack as well as invert and fold into itself thereby for occluding an aneurysm.
- an occlusive device for treating an aneurysm can include a delivery system and a braid being slideably disposed within the microcatheter in a collapsed state.
- the braid can have a distal end opposite a proximal end.
- the braid can include a distal segment between the distal and proximal ends.
- the braid can be distally translatable from within the microcatheter to a deployed state.
- the braid can expand to the deployed state as the distal end of the braid exits the microcatheter causing the distal segment to radially expand to form an occlusive sack for the aneurysm.
- the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a porosity reduced relative to the occlusive sack thereby deflecting, diverting, and/or slowing a flow into the aneurysm.
- the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a higher braid angle relative to the occlusive sack.
- distally translating the braid after the occlusive sack is formed causes one or more segments proximal the distal segment to invert and tuck into the occlusive sack. In some embodiments, wherein the one or more segments proximal the distal segment have an increased braid angle relative to a braid angle of the distal segment to facilitate inversion.
- the braid in the deployed state, is detachable from the delivery system in the aneurysm.
- the delivery system can also include a delivery tube with a distal end and a proximal end. The distal end of the delivery tube can be detachably connected to the proximal end of the braid whereby the delivery tube can be translatably disposable within a microcatheter. The delivery tube can distally translate the braid within the microcatheter from the collapsed state to the deployed state.
- the braid can include a tapered segment disposed between the distal segment and a proximal segment that can be elongate (e.g., partially, substantially, and/or entirely).
- the tapered segment can have a tapered shape.
- the proximal segment can be disposed on or adjacent the proximal end of the braid.
- the occlusive sack of the distal segment can be spherical or any other shape adequate to occlude the aneurysm when in the deployed, expanded state.
- the distal segment can form into the occlusive sack of the braid, which can be located at the neck of the aneurysm, by having the distal segment remain in place in the aneurysm, and the proximal segment translating distally, eventually inverting into the distal segment.
- the occlusive sack can be capable of sealing the neck of the aneurysm.
- the tapered segment is operable to cover the neck of the aneurysm and the proximal segment can be operable to tuck into the occlusive sack formed by the distal segment.
- the tapered segment can divert flow or reduce the velocity of flow into the aneurysm.
- the proximal segment can attach the braid to the distal end of the delivery tube and, after the distal segment has expanded to form the occlusive sack, can initiate inversion of the proximal end of the braid into the occlusive sack of the distal segment.
- inverting the proximal end functions such as a tube sock into the distal segment.
- the occlusive sack of the distal segment can be a collapsible cage-like vaso-occlusive structure.
- the braid can include one or more buckle portions defined between the distal segment and the tapered and/or proximal segments.
- the proximal end of the braid overlaid internal to the occlusive sack of the distal segment can be formed by inverting at the buckle portion, as the braid continues distally translating from the microcatheter and after the occlusive sack of the distal segment is formed by radial expansion.
- the distal segment can also include fewer wire segments than the tapered and proximal segments.
- each of the distal, tapered, and proximal segments can include different braid properties.
- the tapered segment diverts flow as the distal segment forms the occlusive sack adjacent or is against a wall of the aneurysm and the proximal segment inverts into the distal segment at the neck of the aneurysm.
- an imaging device operatively is in communication with the occlusive device, wherein the imaging device is capable of imaging the sack with respect to the aneurysm.
- An orientation of the occlusive sack can be adjustable by the braid being distally or proximally moved.
- a braid for treating an aneurysm can have a distal segment defined between proximal and distal ends of the braid.
- the braid can also have a tapered segment disposed between the distal segment and an proximal segment.
- the proximal segment can be disposed on or adjacent the proximal end.
- the braid can be capable of moving from a collapsed state within a microcatheter to a deployed state external to the microcatheter.
- translating the braid so the distal end is distal of the microcatheter causes the distal segment to radially expand and form an outer occlusive sack.
- the occlusive sack can have a diameter greater than a diameter of the microcatheter.
- translating the braid distally after the outer occlusive sack is formed can cause the tapered segment to invert into the occlusive sack.
- the braid can be detachably deployable by a delivery system to an aneurysm.
- the lumen of the braid can also include a buckle portion disposed between the distal segment and the tapered and/or proximal segments. The buckle portion can cause the tapered segment to invert into the occlusive sack.
- a braid angle of the tapered segment can be adjusted (e.g., increased) compared to a braid angle of the distal segment.
- a method of delivering an occlusive device to an aneurysm in a blood vessel in a patient can include slidably positioning a delivery tube within a microcatheter; slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end; selectively positioning the microcatheter, the delivery tube, and the braid into vasculature of the aneurysm; distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm; causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter; inverting a segment proximal the distal segment into the occlusive sack; and releasing
- the inverting the segment proximal the distal segment into the occlusive sack can deflect, divert, and/or slow a flow into the aneurysm.
- the method can include imaging the occlusive sack of the braid with respect to the aneurysm; determining whether the aneurysm is occluded by the sack; and distally or proximally sliding the braid to adjust the sack and to occlude the aneurysm.
- the method can include adjusting (e.g., increasing) a braid angle of the proximal segment; positioning said segment adjacent or in communication with a neck of the aneurysm; and deflecting, diverting, and/or slowing a flow into the aneurysm when the proximal segment is inverted into the occlusive sack.
- the method can include sealing, by the occlusive sack, the neck of the aneurysm.
- the method can include positioning the distal segment across a neck of the aneurysm; and reducing the porosity of the distal segment relative to the occlusive sack.
- the method can include positioning the distal segment across a neck of the aneurysm; and rendering higher a braid angle relative to the occlusive sack.
- FIG. 1 depicts an example occlusive device of this disclosure deployed into an aneurysm
- FIG. 2 is a schematic side view of an exemplary delivery system with an occlusive device in communication within a microcatheter;
- FIG. 3 is an enlarged schematic side view of the braid of FIGS. 1-2 in an expanded state
- FIG. 4A is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
- FIG. 4B is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
- FIG. 5A is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
- FIG. 5B is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 after the braid is deployed into an example aneurysm;
- FIG. 6A is a perspective schematic view showing an exemplary delivery system for use with an example occlusive device
- FIG. 6B is a perspective schematic view of FIG. 6A but with partial cross-section of the delivery system and the occlusive device;
- FIG. 7A is a perspective schematic view of FIGS. 6A-6B being deployed with partial cross-section of the delivery system and the occlusive device;
- FIG. 7B is a perspective schematic view of FIGS. 6A-6B deployed with the exemplary delivery system detached from the occlusive device;
- FIG. 8 is a flow diagram for a method of delivering an occlusive device.
- FIG. 9 is a flow diagram for a method of delivering an occlusive device.
- vasculature of a “subject” or “patient” may be vasculature of a human or any animal.
- an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc.
- the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like).
- the subject may be any applicable human patient, for example.
- doctor may include a doctor, surgeon, or any other individual or delivery instrumentation associated with delivery of a braid body to the vasculature of a subject.
- the occlusive device 1 and corresponding delivery system 40 disclosed here addresses the drawbacks of previous approaches.
- FIG. 1 an example occlusive device 1 of this disclosure is shown deployed into an aneurysm A of blood vessel BV but not yet released from delivery system 40 .
- the delivery system 40 can include a microcatheter 20 with a delivery tube 30 slideably disposed therein.
- the microcatheter 20 has been delivered to the aneurysm A and an occlusive sack formed by distal segment 12 of braid 10 is shown forming a predetermined shape and structure that outlines and supports the walls of the aneurysm A so as to occlude aneurysm A.
- Segment 12 can be formed on, with, or otherwise about distal end 14 of braid 10 .
- the microcatheter 20 size is selected in consideration of the size, shape, and directionality of the aneurysm or the body lumens the catheter must pass through to get to the treatment site.
- the microcatheter 20 may have a total usable length anywhere from 80 centimeters to 170 centimeters.
- the microcatheter 20 may have an inner diameter ID of anywhere between 0.015 and 0.032 inches.
- the outer diameter OD may also range in size and may narrow at either its proximal end or distal end.
- the microcatheter 20 may be attached to another device, and at its distal end 24 may be operable to positioned at the neck of the aneurysm A. While the distal end 24 of the microcatheter 20 as shown contains the braid 10 , the end 24 may be varied in shape and may curve at an angle.
- System 40 can include a delivery tube 30 and a microcatheter 20 .
- the delivery tube 30 can be capable of being distally pushed from a microcatheter 20 and the delivery tube 30 can have an inner lumen.
- Delivery tube 30 can be substantially elongate and can extend from the proximal 26 to the distal end 24 of microcatheter 20 .
- Tube 30 can generally run along the inner lumen of microcatheter 20 and may leave a space between its outer surface and the internal surface of microcatheter 20 .
- delivery tube 30 and microcatheter 20 may be axially aligned.
- System 40 can deliver braid 10 to a location of interest (e.g. a lesion site) using microcatheter 20 .
- microcatheter 20 can be pre-placed at a level of the aneurysm neck and used to track the device 1 to the lesion.
- Delivery tube 30 can be in mechanical connection with braid 10 at locking portion 54 .
- Braid 10 may be attached to locking portion 54 by slidable attachment, permanent attachment (e.g. crimped, laser, ultrasonic weld, or other sources of heat, adhesive, or the like) or other detachable attachment approaches.
- distally translating, sliding, or otherwise moving tube 30 towards the aneurysm A can cause braid 10 to begin moving from a collapsed condition within microcatheter 20 to a deployed condition external to microcatheter with occlusive sack of segment 12 , as discussed more particularly below.
- the inner lumen of braid 10 can include a distal end 14 and a proximal end 16 .
- the distal end 14 can be opened and/or be capable of allowing for sizing or conforming to the aneurysm A.
- distal end 14 may be a closed end, whereas in a larger aneurysm the same braid 10 can have an open distal end 14 .
- the inner lumen of braid 10 can be formed from a self-expanding and an invertible multi-filament outer surface that can includes a mesh.
- the occlusive sack of braid 10 can be formed during deployment as distal end 14 of braid 10 slides out and exits microcatheter 20 .
- the mesh of braid 10 can be defined by one or more mesh patterns with mesh openings defined by braided filaments.
- the mesh of braid 10 can include a porosity region associated with the occlusive sack formed by braid 10 .
- the mesh of braid 10 can be comprised of a tube of mesh, closed at one end (e.g. proximal end 16 ) and be made of several materials such as deposited thin films.
- the self-expanding mesh of braid 10 can include multiple wires, for example from 4 to 96 wires. The number of wires can be a factor in controlling material properties of the braid 10 , including the stiffness.
- the occlusive sack of braid 10 can be formed by braid 10 being distally translated from a collapsed state within microcatheter 20 and attached to delivery tube 30 .
- the mesh of braid 10 is configured so that as braid 10 is distally translated and its end 14 exits from within microcatheter 20 , segment 12 will begin immediately expanding. As braid 10 is further translated, the segments of braid 10 , including segment 12 and its corresponding occlusive sack, will take shape. Fewer wires of the mesh of braid 10 can be used as a whole.
- the wires can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, Platinum, Nitinol, Stainless Steel, Tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time.
- the apertures in the mesh of braid 10 can also create a substantially unitary frame work or mesh.
- the apertures may be of any size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh of braid 10 .
- the apertures can provide the tubular element of braid 10 with flexibility and also assist in the transformation of the mesh from the collapsed state to the expanded, deployed state, and vice versa.
- FIG. 3 an enlarged schematic side view of the braid 10 of FIGS. 1-2 is shown in a close-up, expanded state.
- Other portions of the mesh of braid 10 can have different porosities and/or other material properties, including segments 11 and 13 of braid 10 .
- the braid 10 can include several segments, including a generally spherical shaped segment associated with sack 12 along with a proximal tapered cone segment 13 leading to a relatively elongate proximal segment 11 .
- Segment 11 of the braid 10 can have porosity less than the porosity of segment 13 and/or the segment of sack 12 .
- the porosities associated with segments 11 , 12 , 13 and/or any other region or segment of braid 10 include filaments having modified braid angles at the different respective regions.
- the braid angle can be modified by removing filaments in the respective region or by adding a coating or covering to a respective region or by selectively modifying the cross section of the wires.
- Portions of braid 10 on or proximate end 16 may be more pliable that portions of braid 10 on or proximate end 14 in order to induce self-expansion during delivery and inversion as braid 10 forms its predetermined, sack-like shape within aneurysm A (see, e.g., segment 12 ).
- the outer surface of braid 10 can also be made from nitinol with interwoven platinum filaments for radiopacity.
- the tapered segment 13 adjacent to the spherical segment 12 can allow the braid 10 to invert on itself (like a sock) as the device 1 is fully deployed in the aneurysm A.
- the braid 10 can be modified to weaken or make it more likely to invert.
- segment 13 can include a buckle portion 17 that includes a localized braid angle change, removal of wire segments, localized heat treatment, and other approaches to change braid properties.
- the braid angle of segment 13 can be increased relative to other portions of braid 10 so that the porosity of braid 10 across the neck is reduced so that a flow into the aneurysm is deflected, diverted, or slowed. This is because segment 13 can be in communication with the neck of the aneurysm when braid 10 is inverted and deployed in the aneurysm, since end 16 can be tucked into segment 12 (e.g., see FIG. 5B ).
- a braid angle of one or some of the segments 11 , 12 , 13 of braid 10 can vary from the longitudinal axis of the braid 10 .
- the wire diameter, pick count (i.e. the number of wire crossovers per lineal measurement) of braid 10 can also vary or otherwise be modified between segments of braid 10 to change the device characteristics.
- the shape of braid 10 and any of its respective segments can also be heat set.
- the fibers of braid 10 can be formed by being fastened at their free ends by heat bonding by laser or ultrasonic weld, solvent or adhesive binding, crimping, or any other attachment means.
- the fibers of each segment of braid 10 may be bonded at their internal crossover points by solvent, adhesive, or heat bonding like laser, ultrasonic weld, or any other source of heat.
- braid 10 is not so limited and it can have a braid angle, pitch count, wire diameter, porosity or any other property of braid 10 that is substantially similar throughout.
- FIGS. 4A to 5B depict an enlarged schematic side view of the delivery system 40 and braid 10 as the braid 10 is being pushed into an example aneurysm A.
- the mesh of braid 10 expands and then proximal end 16 inverts into braid 10 as the occlusive sack of segment 12 of braid 10 is formed. This means that braid 10 inverts along segment 11 in and rests inside of the aneurysm sack once deployed.
- the inversion of the mesh of braid 10 can be formed when the end 14 of the braid 10 is relatively fixed against the wall of aneurysm A while end 16 is distally pushed forward away from microcatheter 20 and tucked into the sack of segment 12 .
- proximal end 16 of braid 10 can begin inverting as the braid 10 moves distally forward as shown in FIG. 4B and braid 10 does not need for the entire length of 10 to be deployed before the braid starts inverting. In other embodiments, once the entire length of braid 10 is deployed and distal of microcatheter 20 , the proximal end 16 can invert and tuck into segment 12 . Regardless, in the deployed state, once selectively positioned and arranged in the proper deployed configuration with respect to aneurysm A, braid 10 can be detached. The inversion of braid 10 can be formed akin to a tube sock. In other embodiments, once the mesh of braid 10 is fully deployed and the occlusive sack of braid 10 is formed within aneurysm A, both the ends 14 , 16 can be next to or adjacent each other.
- the braid 10 can be assembled with a delivery tube 30 and/or within a microcatheter 20 in a collapsed state.
- the herein disclosed novel delivery system 40 and novel braid 10 can be packaged as a portable kit or system.
- the assembly between microcatheter 20 , delivery tube 30 , and/or braid 10 can take place before being introduced into the vasculature.
- the delivery system 40 used with braid 10 which can include microcatheter 20 and delivery tube 30 , can be selectively positioned at the lesion site and delivery tube 30 can begin distally translating braid 10 towards the aneurysm.
- Braid 10 can expand as or upon its delivery end 14 contacting aneurysm A as it distally moves away from distal end 24 of catheter 20 to form the spherical sack associated with segment 12 within aneurysm A.
- segment 12 of braid 10 is beginning to take a generally spherical shape internal to aneurysm A as braid 10 contacts dome D of aneurysm A and/or as braid is translated distally deeper into aneurysm A, further away from catheter 20 and tube 30 .
- Delivery tube 30 may also include one or more fasteners operable to securely fasten braid 10 in place prior to deployment.
- sack 12 can radially expand towards the outer walls of aneurysm A while unexpanded portions (e.g. segment 11 ) of braid 10 continue to be translated by delivery tube 30 .
- delivery tube 30 distally moves further away from microcatheter 20 and braid 10 begins inverting as its end 16 continues moving distally, by delivery tube 30 , away from microcatheter 20 towards aneurysm A.
- Delivery tube 30 may be driven by a hypotube from its proximal end 36 (not depicted) by an operator or the like.
- Microcatheter 20 may remain relatively stationary or fixed while delivery tube 30 can be seen distally translating braid 10 towards and through the neck of aneurysm A.
- Braid 10 can include a pre-weakened or buckle portion 17 so that as braid 10 and delivery tube 30 are distally translated away from microcatheter 20 and into aneurysm A, segment 11 can be translated causing radial expansion of segment 12 to form the corresponding occlusive sack. Continued distal translation of braid 10 can also cause the braid 10 to buckle and for end 16 to invert into sack of segment 12 .
- portion 17 can initiate inversion of end 16 into segment 12 . Inverting end 16 into segment 12 is particularly advantageous as it prevents braid 10 from creating a protrusion that would otherwise extend into the parent vessel. Instead, any such protrusion is now inverted and tucked into segment 12 . Arranging braid 10 in this manner across the neck of the aneurysm, including by inverting end 16 into the sack of segment 12 , a flow diversion is created essentially inside of the sack of segment 12 .
- buckle portion 17 may be formed into the interstices of braid 10 between end 14 of braid 10 and locking portion 54 between braid 10 and delivery tube 30 so that inversion occurs after braid 10 has distally translated a predetermined distance outside of delivery tube 30 .
- Portion 17 may be simply a weak point or buckling point pre-set for a particular sack 12 so that buckling is induced so as to avoid strain of aneurysm A.
- no buckle portion 17 may be included and instead braid 10 may invert and fold into itself upon end 14 of braid contacting the dome D of aneurism A (e.g. based on pre-selected pliability of braid 10 ).
- Locking portion 54 , and/or portions of delivery tube 30 can be at the level of the neck of the aneurysm A as seen under fluoroscopy.
- the outer diameter of the braid 10 about segment 12 radially expands to a diameter greater than the microcatheter 20 as the occlusive sack of segment 12 is formed.
- the delivery system 40 can continue to be distally translated until the junction between end 16 of braid 10 , locking portion 54 , and delivery tube 30 is fully within the spherical, occlusive sack of segment 12 and inversion of braid 10 stops. Once braid 10 , segment 12 , and corresponding inversion of end 16 are selectively positioned and arranged to the desired condition (e.g.
- braid 10 has been translated distally to expand segment 12 to form its sack and segments have been inverted therein), braid 10 can be detached from the delivery tube 30 as shown in FIG. 5B .
- Delivery tube 30 between FIGS. 4A and 5A continues to distally slide braid 10 until in FIG. 5A , unexpanded, segments aft of segment 12 (e.g. segment 13 , segment 11 , or any other segments aft of segment 12 not depicted) invert and be tucked into the sack of segment 12 .
- segments of braid 10 that are proximal of segment 12 can be used to force invert like a tube sock.
- delivery tube 30 can be proximally translated back into microcatheter 20 and retracted from the braid 10 and aneurysm A.
- the braid wire count of interstices of braid 10 that may form the outer surface of its expandable and invertible mesh can vary depending of the diameter of the sack of segment 12 and/or any sacks inverted internal thereto.
- end 14 of braid 10 may be more pliable than the other end 16 , or vice versa, and other segments of braid 10 , including segments 11 , 12 , and 13 , may vary from most pliable on or about end 14 and less pliable on or about end 16 .
- Interstices of braid 10 may also form openings for occlusion of the aneurysm.
- an example spherical sack of segment 12 fully formed in a manner sufficient to occlude aneurysm A with one or more inverted portions disposed internal to the sack of segment 12 , braid 10 can be detached from locking portion 54 .
- braid 10 including segment 12 , can be retracted back into delivery tube 30 by proximally withdrawing delivery tube 30 back into microcatheter 20 while still attached to braid 10 .
- FIGS. 6A to 7B generally illustrate example attachment and delivery between delivery tube 30 and braid 10 for deploying and detaching braid 10 in aneurysm A.
- the embodiments of FIGS. 6A to 7B is merely one way that delivery tube 30 and braid 10 may be attached at end 34 and any number of attachment means are contemplated as needed or required.
- the delivery tube 30 as shown can have a lumen extending from a proximal end 36 to a distal, delivery end 34 .
- FIG. 6A illustrates braid 10 engaged with the locking member 52 and loop wire 58 locked into the locking portion 54 .
- the opening 60 of the loop wire 58 can be placed through the locking portion 54 .
- the locking portion 54 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable. While the locking portion 54 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable. Locking member 52 , in one example, may be an elongated retractable fiber that may extend between ends 24 and 26 of the microcatheter 20 . Locking member 52 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable.
- locking member 52 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable.
- delivery tube 30 may include a compressible portion 38 disposed between its ends 34 and 36 .
- the compressible portion 38 can allow the delivery tube 30 to bend and/or flex. Such flexibility can assist tracking the braid 10 through the microcatheter 20 and the tortuous path through the vasculature.
- the compressible portion 38 can be formed with interference spiral cuts that can allow for gaps to permit bending but in one example, do not act as a spiral-cut spring.
- Compressible portion 38 can be axially adjustable between an elongated condition and a compressed condition. However, any other arrangement allowing axial adjustment (e.g., a wound wire or spiral ribbon) can also be suitable for use with detachment systems according to the present disclosure).
- the compressible portion 38 can be in the elongated condition at rest and automatically or resiliently returns to the elongated condition from a compressed condition, unless otherwise constrained. The function of the compressible portion 38 is described in greater detail herein.
- FIG. 6A a force F was previously applied to place the delivery tube 30 in a compressed state.
- FIG. 6B illustrates the locking member 52 being drawn proximally to begin the release sequence for braid 10 .
- FIG. 7A illustrates the instant the locking member 52 exits the opening 60 and is pulled free of the loop wire 58 .
- the distal end 62 of the loop wire 58 falls away/returns to its preformed shape and exits the locking portion 54 .
- FIG. 7B illustrates the end of the release sequence.
- the compressible portion 38 of the delivery tube 30 has expanded/returned to its original shape and “sprung” forward.
- An elastic force E is imparted by the distal end 34 of the delivery tube 30 to the braid 10 to “push” it away to insure a clean separation and delivery of the braid 10 to the aneurysm A. It is to be understood that the delivery scheme described in FIGS. 6A-7B are merely example approaches to delivery of braid 10 .
- FIG. 8 is a flow diagram for a method 800 of delivering an occlusive device.
- Step 805 includes positioning an occlusive device within a microcatheter and in communication with a delivery tube, the occlusive device including a braid capable of expanding and inverting into itself.
- Step 810 includes distally sliding, by the delivery tube, the braid from the microcatheter.
- Step 815 includes radially expanding, as the braid distally exits the microcatheter, a distal segment of the braid between proximal and distal ends of the braid to form an occlusive sack within the aneurysm.
- Step 820 includes inverting the proximal end of the braid into the occlusive sack.
- Step 825 includes detaching the braid from the delivery tube and withdrawing the delivery tube from the aneurysm.
- FIG. 9 is a flow diagram for a method 900 of delivering an occlusive device.
- Step 905 includes slidably positioning a delivery tube within a microcatheter.
- Step 910 includes slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end. This step can also include detachably attaching the proximal end of the braid to the distal end of the delivery tube.
- Step 915 includes selectively positioning the microcatheter, the delivery tube, and the braid into the vasculature of the aneurysm.
- Step 920 includes distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm.
- Step 925 includes causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter.
- Step 930 includes inverting and/or tucking a proximal segment into the occlusive sack.
- Step 935 includes releasing the braid within the aneurysm and withdrawing the delivery tube and the microcatheter from the aneurysm and the vasculature.
- variations of the braid 10 can include various materials such as nitinol, stainless steel, bio absorbable materials, and polymers. Braid 10 , including any specific portions such as any breaks and corresponding sacks, can be heat set to various configurations such as spherical, oblong, saddle shaped, etc. for the purpose of shaping the initial sack to better match the aneurysm morphology. In addition, the braid 10 can be heat shaped to include weak points to facility the braid buckling once it reaches the dome of the aneurysm.
- any sack formed by the herein discussed braids 10 can be in a spherical shape as depicted or any other shape, as needed or required, such as ellipsoidal, heart-shaped, ovoid, cylindrical, hemispherical, or the like. Further, interstices of braid 10 that form the sack can vary, or be selectively designed, in size or shape along its length depending on how much braid 10 is caused to radially expand as delivery tube 30 is distally moved.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application is a Continuation of U.S. patent application Ser. No. 15/852,887 filed Dec. 22, 2017, the contents which are herein incorporated by reference.
- This disclosure relates to medical instruments, and more particularly, delivery systems for aneurysm therapy.
- Aneurysms can be complicated and difficult to treat. For example, treatment access may be limited or unavailable when an aneurysm is located proximate critical tissues. Such factors are of particular concern with cranial aneurysms due to the brain tissue surrounding cranial vessels the corresponding limited treatment access.
- Prior solutions have included endovascular treatment access whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. In this respect, because the interior walls of the aneurysm may continue being subjected to flow of blood and related pressure, aneurysm rupture remains possible.
- Alternative to endovascular or other surgical approaches can include occlusive devices. Such devices have typically incorporated multiple embolic coils that are delivered to the vasculature using microcatheter delivery systems. For example, when treating cranial aneurysms, a delivery catheter with embolic coils is typically first inserted into non-cranial vasculature through a femoral artery in the hip or groin area. Thereafter, the catheter is guided to a location of interest within the cranium. The sac of the aneurysm can then be filled with the embolic material to create a thrombotic mass that protects the arterial walls from blood flow and related pressure. However, such occlusive devices do have certain shortcomings, including mass effect, which can cause compression on the brain and its nerves.
- One particular type of occlusive approach endeavors to deliver and treat the entrance or “neck” of the aneurysm as opposed to the volume of the aneurysm. In such “neck” approaches, by minimizing blood flow across the neck, then a cessation of flow into the aneurysm may be achieved. In turn, a thrombotic mass may naturally form without having to deliver embolic materials, as previously described. This is preferable to masses formed from embolic material since a natural mass can improve healing by reducing possible distention from arterial walls and permits reintegration into the original parent vessel shape along the neck plane of the aneurysm. It is understood that the neck plane is an imaginary surface where the inner most layer of the parent wall would be but for the aneurysm. However, neck-occlusive approaches are not without drawbacks. It is desired to block the neck of the aneurysm in the parent vessel. Further, embolic coils do not always effectively treat aneurysms as re-canalization of the aneurysm and/or coil compaction can occur over time.
- The solution of this disclosure resolves these and other issues of the art.
- In some aspects, the present disclosure relates to a self-expanding braid for treating an aneurysm. The braid can include a lumen with a distal end opposite a proximal end. Translating the braid can cause the delivery portion to expand and form an occlusive sack as well as invert and fold into itself thereby for occluding an aneurysm.
- In certain embodiments, an occlusive device for treating an aneurysm is provided. The device can include a delivery system and a braid being slideably disposed within the microcatheter in a collapsed state. The braid can have a distal end opposite a proximal end. The braid can include a distal segment between the distal and proximal ends. The braid can be distally translatable from within the microcatheter to a deployed state. The braid can expand to the deployed state as the distal end of the braid exits the microcatheter causing the distal segment to radially expand to form an occlusive sack for the aneurysm.
- In some embodiments, the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a porosity reduced relative to the occlusive sack thereby deflecting, diverting, and/or slowing a flow into the aneurysm.
- In some embodiments, the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a higher braid angle relative to the occlusive sack.
- In some embodiments, distally translating the braid after the occlusive sack is formed causes one or more segments proximal the distal segment to invert and tuck into the occlusive sack. In some embodiments, wherein the one or more segments proximal the distal segment have an increased braid angle relative to a braid angle of the distal segment to facilitate inversion. In some embodiments, in the deployed state, the braid is detachable from the delivery system in the aneurysm. The delivery system can also include a delivery tube with a distal end and a proximal end. The distal end of the delivery tube can be detachably connected to the proximal end of the braid whereby the delivery tube can be translatably disposable within a microcatheter. The delivery tube can distally translate the braid within the microcatheter from the collapsed state to the deployed state.
- In some embodiments, the braid can include a tapered segment disposed between the distal segment and a proximal segment that can be elongate (e.g., partially, substantially, and/or entirely). The tapered segment can have a tapered shape. The proximal segment can be disposed on or adjacent the proximal end of the braid. The occlusive sack of the distal segment can be spherical or any other shape adequate to occlude the aneurysm when in the deployed, expanded state. The distal segment can form into the occlusive sack of the braid, which can be located at the neck of the aneurysm, by having the distal segment remain in place in the aneurysm, and the proximal segment translating distally, eventually inverting into the distal segment. The occlusive sack can be capable of sealing the neck of the aneurysm. In some embodiments, the tapered segment is operable to cover the neck of the aneurysm and the proximal segment can be operable to tuck into the occlusive sack formed by the distal segment. The tapered segment can divert flow or reduce the velocity of flow into the aneurysm. The proximal segment can attach the braid to the distal end of the delivery tube and, after the distal segment has expanded to form the occlusive sack, can initiate inversion of the proximal end of the braid into the occlusive sack of the distal segment. In one embodiment, inverting the proximal end functions such as a tube sock into the distal segment.
- In some embodiments, the occlusive sack of the distal segment can be a collapsible cage-like vaso-occlusive structure. In some embodiment, the braid can include one or more buckle portions defined between the distal segment and the tapered and/or proximal segments. In this regard, the proximal end of the braid overlaid internal to the occlusive sack of the distal segment can be formed by inverting at the buckle portion, as the braid continues distally translating from the microcatheter and after the occlusive sack of the distal segment is formed by radial expansion. The distal segment can also include fewer wire segments than the tapered and proximal segments.
- In some embodiments, each of the distal, tapered, and proximal segments can include different braid properties.
- In some embodiments, the tapered segment diverts flow as the distal segment forms the occlusive sack adjacent or is against a wall of the aneurysm and the proximal segment inverts into the distal segment at the neck of the aneurysm.
- In some embodiments, an imaging device operatively is in communication with the occlusive device, wherein the imaging device is capable of imaging the sack with respect to the aneurysm. An orientation of the occlusive sack can be adjustable by the braid being distally or proximally moved.
- In some embodiments, a braid for treating an aneurysm is provided. The braid can have a distal segment defined between proximal and distal ends of the braid. The braid can also have a tapered segment disposed between the distal segment and an proximal segment. The proximal segment can be disposed on or adjacent the proximal end. The braid can be capable of moving from a collapsed state within a microcatheter to a deployed state external to the microcatheter. In this embodiment, translating the braid so the distal end is distal of the microcatheter causes the distal segment to radially expand and form an outer occlusive sack. The occlusive sack can have a diameter greater than a diameter of the microcatheter. Additionally, translating the braid distally after the outer occlusive sack is formed can cause the tapered segment to invert into the occlusive sack.
- In some embodiments, the braid can be detachably deployable by a delivery system to an aneurysm. The lumen of the braid can also include a buckle portion disposed between the distal segment and the tapered and/or proximal segments. The buckle portion can cause the tapered segment to invert into the occlusive sack. In some embodiments, a braid angle of the tapered segment can be adjusted (e.g., increased) compared to a braid angle of the distal segment.
- In some embodiments, a method of delivering an occlusive device to an aneurysm in a blood vessel in a patient is disclosed. The method can include slidably positioning a delivery tube within a microcatheter; slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end; selectively positioning the microcatheter, the delivery tube, and the braid into vasculature of the aneurysm; distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm; causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter; inverting a segment proximal the distal segment into the occlusive sack; and releasing the braid within the aneurysm and withdrawing the delivery tube and the microcatheter from the aneurysm.
- In some embodiments, the inverting the segment proximal the distal segment into the occlusive sack can deflect, divert, and/or slow a flow into the aneurysm.
- In some embodiments, the method can include imaging the occlusive sack of the braid with respect to the aneurysm; determining whether the aneurysm is occluded by the sack; and distally or proximally sliding the braid to adjust the sack and to occlude the aneurysm.
- In some embodiments, the method can include adjusting (e.g., increasing) a braid angle of the proximal segment; positioning said segment adjacent or in communication with a neck of the aneurysm; and deflecting, diverting, and/or slowing a flow into the aneurysm when the proximal segment is inverted into the occlusive sack.
- In some embodiments, the method can include sealing, by the occlusive sack, the neck of the aneurysm.
- In some embodiments, the method can include positioning the distal segment across a neck of the aneurysm; and reducing the porosity of the distal segment relative to the occlusive sack.
- In some embodiments, the method can include positioning the distal segment across a neck of the aneurysm; and rendering higher a braid angle relative to the occlusive sack.
- Other aspects and features of the present disclosure will become apparent to those of ordinary skill in the art, upon reviewing the following detailed description in conjunction with the accompanying figures.
- Reference will now be made to the accompanying drawings, which are not necessarily drawn to scale.
-
FIG. 1 depicts an example occlusive device of this disclosure deployed into an aneurysm; -
FIG. 2 is a schematic side view of an exemplary delivery system with an occlusive device in communication within a microcatheter; -
FIG. 3 is an enlarged schematic side view of the braid ofFIGS. 1-2 in an expanded state; -
FIG. 4A is an enlarged schematic side view of the delivery system and braid ofFIGS. 1-3 as the braid is being pushed into an example aneurysm; -
FIG. 4B is an enlarged schematic side view of the delivery system and braid ofFIGS. 1-3 as the braid is being pushed into an example aneurysm; -
FIG. 5A is an enlarged schematic side view of the delivery system and braid ofFIGS. 1-3 as the braid is being pushed into an example aneurysm; -
FIG. 5B is an enlarged schematic side view of the delivery system and braid ofFIGS. 1-3 after the braid is deployed into an example aneurysm; -
FIG. 6A is a perspective schematic view showing an exemplary delivery system for use with an example occlusive device; -
FIG. 6B is a perspective schematic view ofFIG. 6A but with partial cross-section of the delivery system and the occlusive device; -
FIG. 7A is a perspective schematic view ofFIGS. 6A-6B being deployed with partial cross-section of the delivery system and the occlusive device; -
FIG. 7B is a perspective schematic view ofFIGS. 6A-6B deployed with the exemplary delivery system detached from the occlusive device; -
FIG. 8 is a flow diagram for a method of delivering an occlusive device; and -
FIG. 9 is a flow diagram for a method of delivering an occlusive device. - Although example embodiments of the disclosed technology are explained in detail herein, it is to be understood that other embodiments are contemplated. Accordingly, it is not intended that the disclosed technology be limited in its scope to the details of construction and arrangement of components set forth in the following description or illustrated in the drawings. The disclosed technology is capable of other embodiments and of being practiced or carried out in various ways.
- It must also be noted that, as used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. By “comprising” or “containing” or “including” it is meant that at least the named compound, element, particle, or method step is present in the composition or article or method, but does not exclude the presence of other compounds, materials, particles, method steps, even if the other such compounds, material, particles, method steps have the same function as what is named.
- In describing example embodiments, terminology will be resorted to for the sake of clarity. It is intended that each term contemplates its broadest meaning as understood by those skilled in the art and includes all technical equivalents that operate in a similar manner to accomplish a similar purpose. It is also to be understood that the mention of one or more steps of a method does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Steps of a method may be performed in a different order than those described herein without departing from the scope of the disclosed technology. Similarly, it is also to be understood that the mention of one or more components in a device or system does not preclude the presence of additional components or intervening components between those components expressly identified.
- As discussed herein, vasculature of a “subject” or “patient” may be vasculature of a human or any animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like). It should be appreciated that the subject may be any applicable human patient, for example.
- As discussed herein, “operator” may include a doctor, surgeon, or any other individual or delivery instrumentation associated with delivery of a braid body to the vasculature of a subject.
- The occlusive device 1 and
corresponding delivery system 40 disclosed here addresses the drawbacks of previous approaches. Turning toFIG. 1 , an example occlusive device 1 of this disclosure is shown deployed into an aneurysm A of blood vessel BV but not yet released fromdelivery system 40. Thedelivery system 40 can include amicrocatheter 20 with adelivery tube 30 slideably disposed therein. InFIG. 1 , themicrocatheter 20 has been delivered to the aneurysm A and an occlusive sack formed bydistal segment 12 ofbraid 10 is shown forming a predetermined shape and structure that outlines and supports the walls of the aneurysm A so as to occludeaneurysm A. Segment 12 can be formed on, with, or otherwise aboutdistal end 14 ofbraid 10. Themicrocatheter 20 size is selected in consideration of the size, shape, and directionality of the aneurysm or the body lumens the catheter must pass through to get to the treatment site. Themicrocatheter 20 may have a total usable length anywhere from 80 centimeters to 170 centimeters. Themicrocatheter 20 may have an inner diameter ID of anywhere between 0.015 and 0.032 inches. The outer diameter OD may also range in size and may narrow at either its proximal end or distal end. At itsproximal end 26, themicrocatheter 20 may be attached to another device, and at itsdistal end 24 may be operable to positioned at the neck of the aneurysm A. While thedistal end 24 of themicrocatheter 20 as shown contains thebraid 10, theend 24 may be varied in shape and may curve at an angle. - Turning to
FIG. 2 , a schematic side view ofbraid 10 anddelivery system 40 is shown in a deployed configuration but prior to being positioned in a location of interest in the vasculature.System 40 can include adelivery tube 30 and amicrocatheter 20. Thedelivery tube 30 can be capable of being distally pushed from amicrocatheter 20 and thedelivery tube 30 can have an inner lumen.Delivery tube 30 can be substantially elongate and can extend from the proximal 26 to thedistal end 24 ofmicrocatheter 20.Tube 30 can generally run along the inner lumen ofmicrocatheter 20 and may leave a space between its outer surface and the internal surface ofmicrocatheter 20. In turn,delivery tube 30 andmicrocatheter 20 may be axially aligned.System 40 can deliverbraid 10 to a location of interest (e.g. a lesion site) usingmicrocatheter 20. In certain embodiments,microcatheter 20 can be pre-placed at a level of the aneurysm neck and used to track the device 1 to the lesion.Delivery tube 30 can be in mechanical connection withbraid 10 at lockingportion 54.Braid 10 may be attached to lockingportion 54 by slidable attachment, permanent attachment (e.g. crimped, laser, ultrasonic weld, or other sources of heat, adhesive, or the like) or other detachable attachment approaches. Whendelivery tube 30 is mechanically attached to braid 10 at lockingportion 54, distally translating, sliding, or otherwise movingtube 30 towards the aneurysm A can causebraid 10 to begin moving from a collapsed condition withinmicrocatheter 20 to a deployed condition external to microcatheter with occlusive sack ofsegment 12, as discussed more particularly below. - The inner lumen of
braid 10 can include adistal end 14 and aproximal end 16. Thedistal end 14 can be opened and/or be capable of allowing for sizing or conforming to the aneurysm A. For example, if the aneurysm is relatively small,distal end 14 may be a closed end, whereas in a larger aneurysm thesame braid 10 can have an opendistal end 14. The inner lumen ofbraid 10 can be formed from a self-expanding and an invertible multi-filament outer surface that can includes a mesh. The occlusive sack ofbraid 10 can be formed during deployment asdistal end 14 ofbraid 10 slides out and exitsmicrocatheter 20. The mesh ofbraid 10 can be defined by one or more mesh patterns with mesh openings defined by braided filaments. For example, the mesh ofbraid 10 can include a porosity region associated with the occlusive sack formed bybraid 10. The mesh ofbraid 10 can be comprised of a tube of mesh, closed at one end (e.g. proximal end 16) and be made of several materials such as deposited thin films. The self-expanding mesh ofbraid 10 can include multiple wires, for example from 4 to 96 wires. The number of wires can be a factor in controlling material properties of thebraid 10, including the stiffness. - The occlusive sack of
braid 10 can be formed bybraid 10 being distally translated from a collapsed state withinmicrocatheter 20 and attached todelivery tube 30. The mesh ofbraid 10 is configured so that asbraid 10 is distally translated and itsend 14 exits from withinmicrocatheter 20,segment 12 will begin immediately expanding. Asbraid 10 is further translated, the segments ofbraid 10, includingsegment 12 and its corresponding occlusive sack, will take shape. Fewer wires of the mesh ofbraid 10 can be used as a whole. The wires can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, Platinum, Nitinol, Stainless Steel, Tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time. - The apertures in the mesh of
braid 10 can also create a substantially unitary frame work or mesh. Thus, the apertures may be of any size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh ofbraid 10. The apertures can provide the tubular element ofbraid 10 with flexibility and also assist in the transformation of the mesh from the collapsed state to the expanded, deployed state, and vice versa. - Turning to
FIG. 3 , an enlarged schematic side view of thebraid 10 ofFIGS. 1-2 is shown in a close-up, expanded state. Other portions of the mesh ofbraid 10 can have different porosities and/or other material properties, includingsegments braid 10. Thebraid 10 can include several segments, including a generally spherical shaped segment associated withsack 12 along with a proximaltapered cone segment 13 leading to a relatively elongateproximal segment 11.Segment 11 of thebraid 10 can have porosity less than the porosity ofsegment 13 and/or the segment ofsack 12. The porosities associated withsegments braid 10 include filaments having modified braid angles at the different respective regions. For example, the braid angle can be modified by removing filaments in the respective region or by adding a coating or covering to a respective region or by selectively modifying the cross section of the wires. Portions ofbraid 10 on orproximate end 16 may be more pliable that portions ofbraid 10 on orproximate end 14 in order to induce self-expansion during delivery and inversion asbraid 10 forms its predetermined, sack-like shape within aneurysm A (see, e.g., segment 12). The outer surface ofbraid 10 can also be made from nitinol with interwoven platinum filaments for radiopacity. The taperedsegment 13 adjacent to thespherical segment 12 can allow thebraid 10 to invert on itself (like a sock) as the device 1 is fully deployed in the aneurysm A. To facilitate inversion of thebraid 10 in thesegment 13, thebraid 10 can be modified to weaken or make it more likely to invert. For example,segment 13 can include abuckle portion 17 that includes a localized braid angle change, removal of wire segments, localized heat treatment, and other approaches to change braid properties. In certain embodiments, the braid angle ofsegment 13 can be increased relative to other portions ofbraid 10 so that the porosity ofbraid 10 across the neck is reduced so that a flow into the aneurysm is deflected, diverted, or slowed. This is becausesegment 13 can be in communication with the neck of the aneurysm whenbraid 10 is inverted and deployed in the aneurysm, sinceend 16 can be tucked into segment 12 (e.g., seeFIG. 5B ). - In certain embodiments, a braid angle of one or some of the
segments braid 10 can vary from the longitudinal axis of thebraid 10. The wire diameter, pick count (i.e. the number of wire crossovers per lineal measurement) ofbraid 10 can also vary or otherwise be modified between segments ofbraid 10 to change the device characteristics. The shape ofbraid 10 and any of its respective segments can also be heat set. The fibers ofbraid 10 can be formed by being fastened at their free ends by heat bonding by laser or ultrasonic weld, solvent or adhesive binding, crimping, or any other attachment means. The fibers of each segment ofbraid 10 may be bonded at their internal crossover points by solvent, adhesive, or heat bonding like laser, ultrasonic weld, or any other source of heat. However, braid 10 is not so limited and it can have a braid angle, pitch count, wire diameter, porosity or any other property ofbraid 10 that is substantially similar throughout. -
FIGS. 4A to 5B depict an enlarged schematic side view of thedelivery system 40 andbraid 10 as thebraid 10 is being pushed into an example aneurysm A. The mesh ofbraid 10 expands and thenproximal end 16 inverts intobraid 10 as the occlusive sack ofsegment 12 ofbraid 10 is formed. This means thatbraid 10 inverts alongsegment 11 in and rests inside of the aneurysm sack once deployed. In one example, the inversion of the mesh ofbraid 10 can be formed when theend 14 of thebraid 10 is relatively fixed against the wall of aneurysm A whileend 16 is distally pushed forward away frommicrocatheter 20 and tucked into the sack ofsegment 12. In certain embodiments,proximal end 16 ofbraid 10 can begin inverting as thebraid 10 moves distally forward as shown inFIG. 4B andbraid 10 does not need for the entire length of 10 to be deployed before the braid starts inverting. In other embodiments, once the entire length ofbraid 10 is deployed and distal ofmicrocatheter 20, theproximal end 16 can invert and tuck intosegment 12. Regardless, in the deployed state, once selectively positioned and arranged in the proper deployed configuration with respect to aneurysm A,braid 10 can be detached. The inversion ofbraid 10 can be formed akin to a tube sock. In other embodiments, once the mesh ofbraid 10 is fully deployed and the occlusive sack ofbraid 10 is formed within aneurysm A, both theends - Prior to the arrangement of
FIG. 4A , thebraid 10 can be assembled with adelivery tube 30 and/or within amicrocatheter 20 in a collapsed state. In this respect, the herein disclosednovel delivery system 40 andnovel braid 10 can be packaged as a portable kit or system. The assembly betweenmicrocatheter 20,delivery tube 30, and/orbraid 10 can take place before being introduced into the vasculature. Thedelivery system 40 used withbraid 10, which can includemicrocatheter 20 anddelivery tube 30, can be selectively positioned at the lesion site anddelivery tube 30 can begin distally translatingbraid 10 towards the aneurysm.Braid 10 can expand as or upon itsdelivery end 14 contacting aneurysm A as it distally moves away fromdistal end 24 ofcatheter 20 to form the spherical sack associated withsegment 12 within aneurysm A. As shown inFIG. 4A ,segment 12 ofbraid 10 is beginning to take a generally spherical shape internal to aneurysm A asbraid 10 contacts dome D of aneurysm A and/or as braid is translated distally deeper into aneurysm A, further away fromcatheter 20 andtube 30.Delivery tube 30 may also include one or more fasteners operable to securely fastenbraid 10 in place prior to deployment. - As shown in
FIG. 4A , sack 12 can radially expand towards the outer walls of aneurysm A while unexpanded portions (e.g. segment 11) ofbraid 10 continue to be translated bydelivery tube 30. InFIG. 4B ,delivery tube 30 distally moves further away frommicrocatheter 20 andbraid 10 begins inverting as itsend 16 continues moving distally, bydelivery tube 30, away frommicrocatheter 20 towards aneurysmA. Delivery tube 30 may be driven by a hypotube from its proximal end 36 (not depicted) by an operator or the like.Microcatheter 20 may remain relatively stationary or fixed whiledelivery tube 30 can be seen distally translatingbraid 10 towards and through the neck ofaneurysm A. Braid 10 can include a pre-weakened orbuckle portion 17 so that asbraid 10 anddelivery tube 30 are distally translated away frommicrocatheter 20 and into aneurysm A,segment 11 can be translated causing radial expansion ofsegment 12 to form the corresponding occlusive sack. Continued distal translation ofbraid 10 can also cause thebraid 10 to buckle and forend 16 to invert into sack ofsegment 12. In certain embodiments,portion 17 can initiate inversion ofend 16 intosegment 12. Invertingend 16 intosegment 12 is particularly advantageous as it prevents braid 10 from creating a protrusion that would otherwise extend into the parent vessel. Instead, any such protrusion is now inverted and tucked intosegment 12. Arrangingbraid 10 in this manner across the neck of the aneurysm, including by invertingend 16 into the sack ofsegment 12, a flow diversion is created essentially inside of the sack ofsegment 12. - It is understood that
buckle portion 17 may be formed into the interstices ofbraid 10 betweenend 14 ofbraid 10 and lockingportion 54 betweenbraid 10 anddelivery tube 30 so that inversion occurs afterbraid 10 has distally translated a predetermined distance outside ofdelivery tube 30.Portion 17 may be simply a weak point or buckling point pre-set for aparticular sack 12 so that buckling is induced so as to avoid strain of aneurysm A. Alternatively, nobuckle portion 17 may be included and instead braid 10 may invert and fold into itself uponend 14 of braid contacting the dome D of aneurism A (e.g. based on pre-selected pliability of braid 10). - Locking
portion 54, and/or portions ofdelivery tube 30 can be at the level of the neck of the aneurysm A as seen under fluoroscopy. In moving betweenFIGS. 4A-5B , the outer diameter of thebraid 10 aboutsegment 12 radially expands to a diameter greater than themicrocatheter 20 as the occlusive sack ofsegment 12 is formed. InFIG. 5A , thedelivery system 40 can continue to be distally translated until the junction betweenend 16 ofbraid 10, lockingportion 54, anddelivery tube 30 is fully within the spherical, occlusive sack ofsegment 12 and inversion ofbraid 10 stops. Oncebraid 10,segment 12, and corresponding inversion ofend 16 are selectively positioned and arranged to the desired condition (e.g. braid 10 has been translated distally to expandsegment 12 to form its sack and segments have been inverted therein),braid 10 can be detached from thedelivery tube 30 as shown inFIG. 5B .Delivery tube 30 betweenFIGS. 4A and 5A continues to distallyslide braid 10 until inFIG. 5A , unexpanded, segments aft of segment 12 (e.g. segment 13,segment 11, or any other segments aft ofsegment 12 not depicted) invert and be tucked into the sack ofsegment 12. In other words, as thebraid 10 is distally translated towards the dome of the aneurysm A, the segments ofbraid 10 that are proximal ofsegment 12 can be used to force invert like a tube sock. In turn,delivery tube 30 can be proximally translated back intomicrocatheter 20 and retracted from thebraid 10 and aneurysm A. - The braid wire count of interstices of
braid 10 that may form the outer surface of its expandable and invertible mesh can vary depending of the diameter of the sack ofsegment 12 and/or any sacks inverted internal thereto. For example, in order to induce formation of the predetermined shape and strength of the occlusive sack ofsegment 12, end 14 ofbraid 10 may be more pliable than theother end 16, or vice versa, and other segments ofbraid 10, includingsegments end 14 and less pliable on or aboutend 16. Interstices ofbraid 10 may also form openings for occlusion of the aneurysm. - In
FIG. 5B , an example spherical sack ofsegment 12 fully formed in a manner sufficient to occlude aneurysm A with one or more inverted portions disposed internal to the sack ofsegment 12,braid 10 can be detached from lockingportion 54. However, if the sack ofsegment 12 is not precisely positioned or ifsegment 12 and/or any internally disposed segments formed by inversion of segments proximal thereto need to be reset or adjusted within aneurysm A for safe occlusion without risk of rupture,braid 10, includingsegment 12, can be retracted back intodelivery tube 30 by proximally withdrawingdelivery tube 30 back intomicrocatheter 20 while still attached to braid 10. InFIG. 5B , since the sack ofsegment 12 has been selectively positioned and formed within aneurysm A,braid 10 has been detached fromdelivery tube 30 anddelivery tube 30 andmicrocatheter 20 can now be retraced from aneurysm A and the lesion site. It is understood that some or all of lockingportion 54 can be formed with themicrocatheter 20 ordelivery tube 30 and/or can be radiopaque so that positioning and detachment can be monitored and/or driven under fluoroscopy. -
FIGS. 6A to 7B generally illustrate example attachment and delivery betweendelivery tube 30 andbraid 10 for deploying and detachingbraid 10 in aneurysm A. The embodiments ofFIGS. 6A to 7B is merely one way thatdelivery tube 30 andbraid 10 may be attached atend 34 and any number of attachment means are contemplated as needed or required. Thedelivery tube 30 as shown can have a lumen extending from aproximal end 36 to a distal,delivery end 34.FIG. 6A illustratesbraid 10 engaged with the lockingmember 52 andloop wire 58 locked into the lockingportion 54. Theopening 60 of theloop wire 58 can be placed through the lockingportion 54. The lockingportion 54 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable. While the lockingportion 54 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable. Lockingmember 52, in one example, may be an elongated retractable fiber that may extend betweenends microcatheter 20. Lockingmember 52 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable. While the lockingmember 52 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable. When the lockingmember 52 is put through theopening 60 thebraid 10 is now secure. It is understood thatdelivery tube 30 may include acompressible portion 38 disposed between itsends - The
compressible portion 38 can allow thedelivery tube 30 to bend and/or flex. Such flexibility can assist tracking thebraid 10 through themicrocatheter 20 and the tortuous path through the vasculature. Thecompressible portion 38 can be formed with interference spiral cuts that can allow for gaps to permit bending but in one example, do not act as a spiral-cut spring.Compressible portion 38 can be axially adjustable between an elongated condition and a compressed condition. However, any other arrangement allowing axial adjustment (e.g., a wound wire or spiral ribbon) can also be suitable for use with detachment systems according to the present disclosure). Thecompressible portion 38 can be in the elongated condition at rest and automatically or resiliently returns to the elongated condition from a compressed condition, unless otherwise constrained. The function of thecompressible portion 38 is described in greater detail herein. - In
FIG. 6A , a force F was previously applied to place thedelivery tube 30 in a compressed state.FIG. 6B illustrates the lockingmember 52 being drawn proximally to begin the release sequence forbraid 10.FIG. 7A illustrates the instant the lockingmember 52 exits theopening 60 and is pulled free of theloop wire 58. Thedistal end 62 of theloop wire 58 falls away/returns to its preformed shape and exits the lockingportion 54. As can be seen, there is now nothing holding thebraid 10 to thedelivery tube 30.FIG. 7B illustrates the end of the release sequence. Here, thecompressible portion 38 of thedelivery tube 30 has expanded/returned to its original shape and “sprung” forward. An elastic force E is imparted by thedistal end 34 of thedelivery tube 30 to thebraid 10 to “push” it away to insure a clean separation and delivery of thebraid 10 to the aneurysm A. It is to be understood that the delivery scheme described inFIGS. 6A-7B are merely example approaches to delivery ofbraid 10. -
FIG. 8 is a flow diagram for amethod 800 of delivering an occlusive device. Step 805 includes positioning an occlusive device within a microcatheter and in communication with a delivery tube, the occlusive device including a braid capable of expanding and inverting into itself. Step 810 includes distally sliding, by the delivery tube, the braid from the microcatheter. Step 815 includes radially expanding, as the braid distally exits the microcatheter, a distal segment of the braid between proximal and distal ends of the braid to form an occlusive sack within the aneurysm. Step 820 includes inverting the proximal end of the braid into the occlusive sack. Step 825 includes detaching the braid from the delivery tube and withdrawing the delivery tube from the aneurysm. -
FIG. 9 is a flow diagram for amethod 900 of delivering an occlusive device. Step 905 includes slidably positioning a delivery tube within a microcatheter. Step 910 includes slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end. This step can also include detachably attaching the proximal end of the braid to the distal end of the delivery tube. Step 915 includes selectively positioning the microcatheter, the delivery tube, and the braid into the vasculature of the aneurysm. Step 920 includes distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm. Step 925 includes causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter. Step 930 includes inverting and/or tucking a proximal segment into the occlusive sack. Step 935 includes releasing the braid within the aneurysm and withdrawing the delivery tube and the microcatheter from the aneurysm and the vasculature. - It is understood that variations of the
braid 10 can include various materials such as nitinol, stainless steel, bio absorbable materials, and polymers.Braid 10, including any specific portions such as any breaks and corresponding sacks, can be heat set to various configurations such as spherical, oblong, saddle shaped, etc. for the purpose of shaping the initial sack to better match the aneurysm morphology. In addition, thebraid 10 can be heat shaped to include weak points to facility the braid buckling once it reaches the dome of the aneurysm. It is also understood that any sack formed by the herein discussedbraids 10 can be in a spherical shape as depicted or any other shape, as needed or required, such as ellipsoidal, heart-shaped, ovoid, cylindrical, hemispherical, or the like. Further, interstices ofbraid 10 that form the sack can vary, or be selectively designed, in size or shape along its length depending on howmuch braid 10 is caused to radially expand asdelivery tube 30 is distally moved. - The specific configurations, choice of materials and the size and shape of various elements can be varied according to particular design specifications or constraints requiring a system or method constructed according to the principles of the disclosed technology. Such changes are intended to be embraced within the scope of the disclosed technology. The presently disclosed embodiments, therefore, are considered in all respects to be illustrative and not restrictive. It will therefore be apparent from the foregoing that while particular forms of the disclosure have been illustrated and described, various modifications can be made without departing from the spirit and scope of the disclosure and all changes that come within the meaning and range of equivalents thereof are intended to be embraced therein.
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/924,571 US20200337710A1 (en) | 2017-12-22 | 2020-07-09 | Aneurysm device and delivery system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/852,887 US10716574B2 (en) | 2017-12-22 | 2017-12-22 | Aneurysm device and delivery method |
US16/924,571 US20200337710A1 (en) | 2017-12-22 | 2020-07-09 | Aneurysm device and delivery system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/852,887 Continuation US10716574B2 (en) | 2017-12-22 | 2017-12-22 | Aneurysm device and delivery method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200337710A1 true US20200337710A1 (en) | 2020-10-29 |
Family
ID=64746170
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/852,887 Active 2038-04-17 US10716574B2 (en) | 2017-12-22 | 2017-12-22 | Aneurysm device and delivery method |
US16/924,571 Abandoned US20200337710A1 (en) | 2017-12-22 | 2020-07-09 | Aneurysm device and delivery system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/852,887 Active 2038-04-17 US10716574B2 (en) | 2017-12-22 | 2017-12-22 | Aneurysm device and delivery method |
Country Status (13)
Country | Link |
---|---|
US (2) | US10716574B2 (en) |
EP (1) | EP3501428B1 (en) |
JP (1) | JP7317499B2 (en) |
KR (1) | KR20190076915A (en) |
CN (1) | CN109984800A (en) |
AU (1) | AU2018282472A1 (en) |
BR (1) | BR102018076836A2 (en) |
CA (1) | CA3028424A1 (en) |
ES (1) | ES2880405T3 (en) |
IL (1) | IL263829A (en) |
MX (1) | MX2019000233A (en) |
RU (1) | RU2018145543A (en) |
TW (1) | TW201934087A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US11648013B2 (en) | 2016-03-11 | 2023-05-16 | Cerus Endovascular Limited | Occlusion device |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US11957356B2 (en) | 2022-02-24 | 2024-04-16 | NV MEDTECH, Inc. | Methods and apparatus for stent assisted aneurysm coiling |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11583289B2 (en) | 2008-05-01 | 2023-02-21 | Aneuclose Llc | Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation |
US12004750B2 (en) | 2008-05-01 | 2024-06-11 | Aneuclose Llc | Methods for creating an expandable two-part intrasacular aneurysm occlusion device from a tubular mesh |
US11471164B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US11357511B2 (en) | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
US11484322B2 (en) | 2018-01-03 | 2022-11-01 | Aneuclose Llc | Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
EP3261703A4 (en) | 2015-02-25 | 2018-10-24 | Galaxy Therapeutics, LLC | System for and method of treating aneurysms |
KR20190115474A (en) * | 2017-02-23 | 2019-10-11 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | Aneurysm device and delivery system |
US11185335B2 (en) | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11596412B2 (en) * | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11058430B2 (en) | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) * | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11051825B2 (en) | 2018-08-08 | 2021-07-06 | DePuy Synthes Products, Inc. | Delivery system for embolic braid |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11272939B2 (en) | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
US11602350B2 (en) * | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US12102327B2 (en) | 2019-05-25 | 2024-10-01 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11058431B2 (en) | 2019-05-25 | 2021-07-13 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
DE102019121546B4 (en) * | 2019-08-09 | 2024-02-08 | Acandis Gmbh | Medical set and medical system for the treatment of aneurysms |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
DE102020118301A1 (en) * | 2019-12-23 | 2021-06-24 | Femtos Gmbh | Implant for the treatment of aneurysms |
US20220031334A1 (en) * | 2020-07-31 | 2022-02-03 | Covidien Lp | Expandable devices for treating body lumens |
US20220087681A1 (en) * | 2020-09-23 | 2022-03-24 | DePuy Synthes Products, Inc. | Inverting braided aneurysm implant with dome feature |
CN112656477B (en) * | 2020-12-31 | 2023-06-20 | 杭州德诺脑神经医疗科技有限公司 | Aneurysm occlusion device and microcatheter therefor |
WO2022164957A1 (en) | 2021-01-27 | 2022-08-04 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
CN113017950A (en) * | 2021-02-08 | 2021-06-25 | 北京联合大学 | Hemispherical braided stent and manufacturing method thereof |
CN116831679B (en) * | 2023-09-02 | 2023-11-14 | 杭州亿科医疗科技有限公司 | Aneurysm vortex device easy to release |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050251200A1 (en) * | 2002-08-29 | 2005-11-10 | Stephen Porter | Device for closure of a vascular defect and method for treating the same |
US20140135812A1 (en) * | 2012-11-13 | 2014-05-15 | Covidien Lp | Occlusive devices |
US20150374483A1 (en) * | 2013-03-15 | 2015-12-31 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US20160249934A1 (en) * | 2013-08-16 | 2016-09-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US20180374483A1 (en) * | 2017-06-21 | 2018-12-27 | Saida Ashley Florexil | Interpreting assistant system |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US20030195553A1 (en) | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
BE1016067A3 (en) | 2004-06-03 | 2006-02-07 | Frid Noureddine | Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT. |
EP1827250B1 (en) * | 2004-08-31 | 2018-05-16 | Cook Medical Technologies LLC | Device for treating an aneurysm |
EP1804719A2 (en) | 2004-09-22 | 2007-07-11 | Lee R. Guterman | Cranial aneurysm treatment arrangement |
EP1827251B8 (en) | 2004-11-09 | 2013-12-11 | Stryker Corporation | Vaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion |
US20080281350A1 (en) | 2006-12-13 | 2008-11-13 | Biomerix Corporation | Aneurysm Occlusion Devices |
US9232992B2 (en) | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US8758423B2 (en) | 2009-06-18 | 2014-06-24 | Graftcraft I Goteborg Ab | Device and method for treating ruptured aneurysms |
WO2011057002A2 (en) | 2009-11-05 | 2011-05-12 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
CA2812012C (en) | 2010-09-10 | 2018-01-02 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
US8764787B2 (en) | 2011-06-17 | 2014-07-01 | Aga Medical Corporation | Occlusion device and associated deployment method |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
US20130204351A1 (en) | 2012-02-02 | 2013-08-08 | Inceptus Medical LLC | Aneurysm Graft Devices And Methods |
US10342546B2 (en) | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
CN108433769B (en) | 2013-03-15 | 2021-06-08 | 柯惠有限合伙公司 | Occlusion device |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
WO2015160721A1 (en) | 2014-04-14 | 2015-10-22 | Sequent Medical Inc. | Devices for therapeutic vascular procedures |
BR102014014407A2 (en) | 2014-06-12 | 2016-04-19 | Biocelere Agroindustrial Ltda | expression cassette to transform eukaryotic cell, genetically modified micro-organism with efficient xylose consumption, process for biofuel and biochemical production and biofuel and / or biochemical thus produced |
EP3171793B1 (en) | 2014-08-14 | 2024-07-24 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
CN204683687U (en) | 2015-04-15 | 2015-10-07 | 中国人民解放军第二军医大学 | A kind of intracranial aneurysm neck reconstructing device |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
JP7129336B2 (en) * | 2016-02-10 | 2022-09-01 | マイクロベンション インコーポレイテッド | vascular occlusion device |
KR20190115474A (en) | 2017-02-23 | 2019-10-11 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | Aneurysm device and delivery system |
-
2017
- 2017-12-22 US US15/852,887 patent/US10716574B2/en active Active
-
2018
- 2018-12-19 ES ES18214052T patent/ES2880405T3/en active Active
- 2018-12-19 EP EP18214052.5A patent/EP3501428B1/en active Active
- 2018-12-19 IL IL263829A patent/IL263829A/en unknown
- 2018-12-21 RU RU2018145543A patent/RU2018145543A/en not_active Application Discontinuation
- 2018-12-21 AU AU2018282472A patent/AU2018282472A1/en not_active Abandoned
- 2018-12-21 JP JP2018239168A patent/JP7317499B2/en active Active
- 2018-12-21 CA CA3028424A patent/CA3028424A1/en active Pending
- 2018-12-21 BR BR102018076836-0A patent/BR102018076836A2/en not_active Application Discontinuation
- 2018-12-21 TW TW107146492A patent/TW201934087A/en unknown
- 2018-12-24 KR KR1020180168493A patent/KR20190076915A/en active Search and Examination
- 2018-12-24 CN CN201811580100.0A patent/CN109984800A/en not_active Withdrawn
-
2019
- 2019-01-07 MX MX2019000233A patent/MX2019000233A/en unknown
-
2020
- 2020-07-09 US US16/924,571 patent/US20200337710A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050251200A1 (en) * | 2002-08-29 | 2005-11-10 | Stephen Porter | Device for closure of a vascular defect and method for treating the same |
US20140135812A1 (en) * | 2012-11-13 | 2014-05-15 | Covidien Lp | Occlusive devices |
US20150374483A1 (en) * | 2013-03-15 | 2015-12-31 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US20160249934A1 (en) * | 2013-08-16 | 2016-09-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US20180374483A1 (en) * | 2017-06-21 | 2018-12-27 | Saida Ashley Florexil | Interpreting assistant system |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
US11389174B2 (en) | 2014-04-30 | 2022-07-19 | Cerus Endovascular Limited | Occlusion device |
US12029431B2 (en) | 2014-04-30 | 2024-07-09 | Stryker Ireland Technology, Ltd. | Occlusion device |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US12076022B2 (en) | 2015-12-07 | 2024-09-03 | Stryker Ireland Technology Ltd. | Occlusion device |
US11648013B2 (en) | 2016-03-11 | 2023-05-16 | Cerus Endovascular Limited | Occlusion device |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US11957356B2 (en) | 2022-02-24 | 2024-04-16 | NV MEDTECH, Inc. | Methods and apparatus for stent assisted aneurysm coiling |
Also Published As
Publication number | Publication date |
---|---|
EP3501428B1 (en) | 2021-04-28 |
RU2018145543A (en) | 2020-06-22 |
AU2018282472A1 (en) | 2019-07-11 |
BR102018076836A2 (en) | 2019-07-02 |
US10716574B2 (en) | 2020-07-21 |
CA3028424A1 (en) | 2019-06-22 |
JP2019111342A (en) | 2019-07-11 |
IL263829A (en) | 2019-03-31 |
CN109984800A (en) | 2019-07-09 |
MX2019000233A (en) | 2019-09-04 |
ES2880405T3 (en) | 2021-11-24 |
JP7317499B2 (en) | 2023-07-31 |
US20190192168A1 (en) | 2019-06-27 |
TW201934087A (en) | 2019-09-01 |
EP3501428A1 (en) | 2019-06-26 |
KR20190076915A (en) | 2019-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200337710A1 (en) | Aneurysm device and delivery system | |
US10939915B2 (en) | Aneurysm device and delivery system | |
US11672540B2 (en) | Aneurysm device and delivery system | |
US11058430B2 (en) | Aneurysm device and delivery system | |
US11596412B2 (en) | Aneurysm device and delivery system | |
US20200375607A1 (en) | Aneurysm device and delivery system | |
US20200375606A1 (en) | Aneurysm method and system | |
JP2019126734A5 (en) | ||
US20210338247A1 (en) | Double layer braid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LORENZO, JUAN;GOROCHOW, LACEY;SOTO DEL VALLE, ARIEL;SIGNING DATES FROM 20181218 TO 20190807;REEL/FRAME:053163/0438 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |